
Dr Talia Eilon
Clinical Research Associate – IMAT (Immune Mechanisms of Antipsychotic Treatment Response)
Biography
Talia Eilon is a Clinical Research Associate at the Institute of Psychiatry, Psychology & Neuroscience at King's College London working in the Wellcome Trust funded Immune Mechanisms of Antipsychotic Treatment Response study. Talia is a medical doctor who completed her MRCPsych accreditation while training across the North Central London Mental Health Partnership.
After completing core psychiatry training she worked as the national neuropsychiatrist for the adult Duchenne Muscular Dystrophy Neuropsychiatry Clinic at the National Hospital for Neurology and Neurosurgery, and as a member of the Duchenne Muscular Dystrophy Care UK psychosocial working group, funded by the Duchenne Research Fund. She also worked as an SpR at Great Ormond Street Hospital in the CAMHS psychiatry department within the Autism Spectrum service and the national neurodevelopmental 22q11 Deletion Syndrome Clinic.
Talia completed her Medical degree (MBChB) at the University of Birmingham in 2017 and holds an intercalated BA in Medical Humanities from the University of Bristol.
Research Interests
- Neuropsychiatry
- Immunopsychiatry
- Child and Adolescent Psychiatry
Research

Neuropsychiatry Research & Education Group (NREG)
Interdisciplinary Neuropsychiatry group | Institute of Psychiatry Psychology & Neuroscience | King’s Health Partners (Academic Health Sciences Centre at King’s College London)
Research

Neuropsychiatry Research & Education Group (NREG)
Interdisciplinary Neuropsychiatry group | Institute of Psychiatry Psychology & Neuroscience | King’s Health Partners (Academic Health Sciences Centre at King’s College London)